摘要
目的:对观察风府刺血疗法改善脑卒中后口腔期吞咽障碍的临床疗效,为临床脑卒中后吞咽障碍患者提供一种新方法。方法:将符合脑卒中诊断标准并伴有口腔期吞咽障碍的68例脑卒中患者,采用随机单盲平行对照和患者自身前后对照的研究方法分为治疗组与对照组,每组34例,两组按洼田饮水试验进行评估,两组给予相同的背景治疗,治疗组在对照组基础治疗上加用风府刺血疗法,每周2次,4周为1个疗程,1个疗程结束后再按洼田饮水试验进行评估,比较两组治疗方法对脑卒中口腔期吞咽障碍影响的差异。结果:治疗组和对照组的吞咽障碍在治疗后均有明显改善,组间比较有明显差异(P<0.05)。结论:风府刺血法可以提高脑卒中后口腔期吞咽障碍疗效。
Objective：To observe the clinical efficacy of Fengfu（DU16） bloodletting therapy to develop a new method for stroke patients with dysphagia.Methods：68 patients with stroke who met the diagnostic criteria for stroke and accompanied by dysphagia,using single-blind,parallel-group randomized and controlled study,were divided into treatment group and control group,34 cases in each.Before treatment,Kubota drinking water test was used to assess the background of the two groups.The same treatment was given to both two groups.The treatment group added Fengfu（DU16） bloodletting therapy twice a week,for 4weeks as a course of treatment.After one course of treatment,Kubota drinking water test was used to evaluate the effects of two groups.Results：The treatment group and the control group＇s dysphagia effects were significantly improved after treatment and there were significant differences between the two groups（P〈0.05）.Conclusion：Dysphagia after stroke could be improved by Fengfu（DU16） bloodletting therapy.
出处
《辽宁中医杂志》
CAS
北大核心
2015年第4期850-851,共2页
Liaoning Journal of Traditional Chinese Medicine
基金
国家中医药管理局中医康复技术科研三级实验室
